HLN.L Haleon plc
Company Analysis
Latest News
🟢 Haleon is trading 4.12% up today amid a broader consumer-staples rally
Haleon is trading 4.12% up at £339.00, alongside a broader consumer-staples rally; this is consistent with sector support but does not establish a direct...
Haleon's Growth Story Catches a Cold — Can a Buyback Cure What Ails Shareholders?
Shares cratered as much as 17% after the Sensodyne and Advil maker slashed its 2026 growth outlook, raising a pointed question: is Haleon's path to becoming a...
🔴 Haleon is trading 15% down today after cutting 2026 growth guidance to 2.5%
Haleon is trading at £317.70, down 15.05%, after cutting its 2026 organic revenue growth guidance. - Guidance is now around 2.5%, down from 3%–5%, after...
🔴 Haleon is trading 11% down after cutting 2026 organic revenue growth outlook
Haleon is trading at £333.83, down 10.74%, after cutting its 2026 organic revenue growth outlook and reporting a third-quarter miss. - On October 29, Haleon...
Haleon boosts sales 24%, targeting GLP-1 users with dedicated CVS sections
Haleon increased U.S. sales by marketing products to consumers experiencing side effects from GLP-1 weight-loss drugs. The company partnered with CVS to create...
Haleon Completes £500M Buyback and $2B Debt Offer to Return Value
Haleon plc completed its £500 million share repurchase program originally announced on March 12, 2026. The company purchased 1,569,800 shares for cancellation...